Autonomix Medical, Inc.

A cyberattack could cause operational problems, disrupt service to clinical trial sites, compromise data or systems, or release confidential information.

A decline in funding or liquidity could impair meeting operating expenses or obligations, cause breaches of financial or contractual obligations, or violate federal or state wage and hour laws, with material adverse impacts on liquidity, business operations and financial condition.

A decrease in volatility and expected term will decrease the estimated fair value of the warrant, while an increase in these factors will have an opposite effect.

Item 7A. Quantitative and Qualitative Disclosure About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

A defendant or licensee may challenge patent validity, including through USPTO post-grant proceedings such as inter partes review and post grant review, and courts could hold patents invalid or not infringed.

A disruption or failure of our systems or operations in the event of a natural disaster or severe weather event, including, but not limited to, earthquakes, wildfires, droughts, flooding, tornadoes, hurricanes or tsunamis, health pandemic, such as an influenza outbreak within our workforce, or man-made catastrophic event could cause delays in completing sales, continuing production or performing other critical functions of our business, particularly if a catastrophic event were to occur at our premises. Global climate change could result in certain natural disasters occurring more frequently or with greater intensity. Any of these events could severely affect our ability to conduct normal business operations and, as a result, our operating results could be adversely affected. There may also be secondary impacts that are unforeseeable as well, such as impacts on our customers, which could cause delays in new orders, delays in completing sales or even order cancellations.